Media headlines about Liquidia Technologies (NASDAQ:LQDA) have been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Liquidia Technologies earned a daily sentiment score of 0.05 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.9895776378721 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

LQDA stock traded up $1.02 during mid-day trading on Tuesday, hitting $19.99. The stock had a trading volume of 2,183 shares, compared to its average volume of 48,913. Liquidia Technologies has a 52 week low of $10.52 and a 52 week high of $18.99.

LQDA has been the subject of several analyst reports. Jefferies Financial Group initiated coverage on shares of Liquidia Technologies in a research note on Monday, August 20th. They issued a “buy” rating and a $22.00 price objective for the company. Needham & Company LLC initiated coverage on shares of Liquidia Technologies in a research note on Monday, August 20th. They issued a “buy” rating and a $30.00 price objective for the company. Cowen initiated coverage on shares of Liquidia Technologies in a research note on Monday, August 20th. They issued an “outperform” rating and a $40.00 price objective for the company. Finally, Wedbush initiated coverage on shares of Liquidia Technologies in a research note on Tuesday, September 4th. They issued an “outperform” rating and a $26.00 price objective for the company.

In other news, major shareholder Viii Lp Canaan bought 727,273 shares of the firm’s stock in a transaction on Monday, July 30th. The shares were purchased at an average cost of $11.00 per share, with a total value of $8,000,003.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Plc Glaxosmithkline bought 148,818 shares of the firm’s stock in a transaction on Monday, July 30th. The stock was purchased at an average cost of $11.00 per share, for a total transaction of $1,636,998.00. The disclosure for this purchase can be found here.

About Liquidia Technologies

There is no company description available for Liquidia Technologies Inc

Further Reading: Discover Your Risk Tolerance

Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.